HUMIRA

Type: Product
Name: HUMIRA
First reported 7 hours ago - Updated 7 hours ago - 1 reports

Celgene Expected To Post Robust Results On Strength In Oncology Portfolio

at 1:47 pm ESTClick Ticker to See live coverageCelgene Corporation ( CELG ) will announce financial results for the second quarter of its fiscal ‘14 (2QFY14; ended June 30, 2014) before the opening bell tomorrow. The biotechnology company looks poised ... [Published Bidness Etc - 7 hours ago]
First reported 9 hours ago - Updated 9 hours ago - 1 reports

$9.9M 'golden hello' awaits Shire chief Ornskov at new AbbVie post

When AbbVie ($ABBV) buys out Shire ($SHPG) for nearly $55 billion in a deal the two companies agreed on last week, there will be no golden parachute awaiting Shire chief Flemming Ornskov. Instead, there's a signing bonus in order: The helmsman will pocket ... [Published FiercePharma - 9 hours ago]
First reported Jul 22 2014 - Updated Jul 23 2014 - 2 reports

US firms racing to close tax inversion deals

[WASHINGTON] US companies are racing to complete tax-reducing offshore mergers before a credible threat to stop them emerges from Congress.AbbVie Inc, maker of the arthritis medicine Humira, announced the largest such inversion deal last Friday with a ... [Published Business Times Singapore - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 2 reports

Shire acquisition could save AbbVie $8bn tax on Humira over 15 years, says GlobalData

AbbVie's relocation to Ireland following the acquisition of Shire for $54bn is expected to reduce the annual tax expense for the company by more than 7%, according to research and consulting firm GlobalData.GlobalData analyst Aparna Krishnan and healthcare ... [Published Pharmaceutical Technology - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Biosimilars set to boom as new patent cliff on biologic superstars looms

If you look at the biosimilars market as a global whole, the sum total of revenue generated by the follow-on crowd just barely crossed into blockbuster territory in 2013, according to a new study from Allied Marketing Research. But that $1.3 billion base ... [Published FierceBiotech - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Here's What You Need to Know About AbbVie and GlaxoSmithKline's Upcoming Earnings

The health care sector has had a bumpy year so far to say the least. Mr. market appears unsure what to make of record high valuations across the sector, the newly implemented Affordable Care Act, and the host of geopolitical events unfolding right now. ... [Published Motley Fool - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 2 reports

Congress may crimp offshore merger tax relief

American companies are racing to complete tax-reducing offshore mergers before a credible threat to stop them emerges from Congress.AbbVie Inc., maker of the arthritis medicine Humira, on Friday announced the largest such inversion deal with a plan to ... [Published Pittsburgh Tribune Review - Jul 22 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 3 reports

AbbVie Set to Acquire UK-Based Shire in Q4

AbbVie Inc. ( ABBV - Analyst Report ) and Shire ( SHPG - Analyst Report ) have finally reached an agreement regarding the proposed acquisition of the latter by the former. As per the terms of the merger, AbbVie will pay approximately £53.19 per Shire ... [Published Zacks.com - Jul 21 2014]
First reported Jul 18 2014 - Updated Jul 19 2014 - 3 reports

Shire to move HQ to Jersey from Dublin as deal agreed

Dublin-based Shire will move its notional headquarters to Jersey after US drugmaker AbbVie agreed to buy the company in a £32bn deal that will allow it to slash its tax bill by relocating to Britain. Dublin-based Shire will move its notional headquarters ... [Published Irish Independent - Jul 19 2014]
Entities: AbbVie Inc, Dublin, HUMIRA
First reported Jul 17 2014 - Updated Jul 18 2014 - 13 reports

AbbVie insists Shire deal will not lead to job cuts in Chicago area

BY FRANCINE KNOWLESStaff Reporter July 18, 2014 3:42PMAbbott / abbvie headquarters in North Chicago, July, 18, 2014. | Michael Schmidt/Sun-TimesChicago-area AbbVie Inc. employees worried about job security after the pharmaceutical firm’s planned $55 billion ... [Published Chicago Sun-Times - Jul 18 2014]
First reported Jul 17 2014 - Updated Jul 18 2014 - 6 reports

It's on: Shire and AbbVie agree £32bn takeover

After weeks of playing hard-to-get, Shire has finally agreed a formal takeover offer from AbbVie that could slash the US firm's corporate tax rate.The final agreement values the Irish firm at £32bn ($55bn) and consists of 0.896 new AbbVie shares and £24.44 ... [Published PMLive - Jul 18 2014]
First reported Jul 17 2014 - Updated Jul 17 2014 - 3 reports

Shire, AbbVie to announce $53 billion merger by Friday: sources

REUTERS — 25 MINUTES AGOBy Olivia Oran and Soyoung Kim(Reuters) - Shire Plc ( Symbol : SHPG ) and U.S. drugmaker Abbvie Inc ( Symbol : ABBV ) plan to announce a $53 billion merger as soon as Friday morning, two people said on Thursday.Dublin-based Shire, ... [Published Fidelity Brokerage Services LLC - Jul 17 2014]

Quotes

"That is an area that we are very, very excited about," Gonzalez said. "We believe it is a very high-touch kind of business, so we want to set it up in a separate individual business unit to make sure that we can maintain that patient focus that Shire has."
...these deals along, it becomes harder and harder to hold to that May effective date," said Robert Willens, a corporate tax consultant in New York. "The bankers and the lawyers are telling them that, 'Hey, the sooner you announce this thing, the greater the chances are that the deal will go through as you intend.'"
"By shifting the legal headquarters of the newly combined entity to Ireland, AbbVie could lower its annual tax expense by as much as 7%, which would have equated to increased earnings of more than $350m in 2013."
...league pharma groups like Novartis ( $NVS ) and Amgen ( $AMGN ) have been partnering up to take advantage of expected openings in the Asian market "as the demand for cost effective treatment is growing due to the prevalence of chronic diseases."

More Content

All (443) | News (414) | Reports (0) | Blogs (28) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Biotech Stock Roundup: AbbVie's Tax Inversion, ... [Published Nasdaq - 7 hours ago]
Why organic isn't just a fad [Published New Hope 360 - 7 hours ago]
Celgene Expected To Post Robust Results On Stre... [Published Bidness Etc - 7 hours ago]
Market Update (NYSE:ABBV): AbbVie to Host Secon... [Published Jutia Group - 8 hours ago]
Durbin: A decision to desert America [Published Chicago Tribune - 9 hours ago]
$9.9M 'golden hello' awaits Shire chief Ornskov... [Published FiercePharma - 9 hours ago]
US firms racing to close tax inversion deals [Published Business Times Singapore - Jul 22 2014]
Shire acquisition could save AbbVie $8bn tax on... [Published Pharmaceutical Technology - Jul 22 2014]
Top Drugs of 2013 [Published Pharmacy Times - Jul 22 2014]
Biosimilars set to boom as new patent cliff on ... [Published FierceBiotech - Jul 22 2014]
Shire Takeover "Could Save AbbVie $8 Billion Ta... [Published Pharmaceutical Executive - Jul 22 2014]
MARLETTA TO STEP DOWN AS SCRIPPS CHIEF [Published U-T San Diego - Jul 22 2014]
Here's What You Need to Know About AbbVie and G... [Published Motley Fool - Jul 22 2014]
Merger rush to offshore tax break bets on Congr... [Published North Jersey.com - Jul 22 2014]
Congress may crimp offshore merger tax relief [Published Pittsburgh Tribune Review - Jul 22 2014]
Report from Asia: Rani insulin delivery system ... [Published Medical Device Daily - Jul 22 2014]
AbbVie Acquires Shire [Published Business Monitor International - Jul 22 2014]
AbbVie Buys Dublin-based Shire for $54.7 billion [Published Pharmaceutical Manufacturing Magazine - Jul 21 2014]
Yahoo buying S.F.'s Flurry analytics firm [Published San Francisco Chronicle - Jul 21 2014]
Shire, AbbVie join forces for $55B [Published Medical Marketing And Media - Jul 21 2014]
AbbVie's Acquisition of Shire Could Save $8 Bil... [Published PharmTech.com - Jul 21 2014]
Role changes for AbbVie and Shire CEOs after me... [Published In-Pharmatechnologist - Jul 21 2014]
Pfizer's Stock Falls Ill as the Dow Tumbles [Published Motley Fool - Jul 21 2014]
AbbVie Acquires Shire To Reincorporate In U.K. [Published Bioresearch Online - Jul 21 2014]
AbbVie Set to Acquire UK-Based Shire in Q4 [Published Zacks.com - Jul 21 2014]
Welcome to Ireland, AbbVie [Published Motley Fool Discussion Boards - Jul 21 2014]
AbbVie reaches a deal with Shire [Published Drug Store News - Jul 21 2014]
AbbVie Buys Shire for $54 Billion [Published The Scientist - Jul 21 2014]
AbbVie reaches agreement for takeover of Shire [Published Zenopa - Jul 21 2014]
AbbVie secures £32bn Shire deal [Published Laboratorytalk - Jul 21 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
AbbVie Flees U.S. Tax Burden With $54B Shire Deal [Published Wall St. Cheat Sheet - Jul 18 2014]
Filippo Monteforte/AFP/Getty Images It’s a familiar story; American drugmakers are looking to reduce their tax burdens by staking out new headquarters abroad, as was perhaps epitomized by Pfizer’s drawn-out pursuit of AstraZeneca, mere months ago now. ...
AbbVie Reels in Shire [Published The Big Red Biotech Blog - Jul 15 2014]
Yesterday's reports all seem to affirm that Abbvie will acquire shire for approximately $53.7 B which represents nearly a 42% premium over Shire's share price before AbbVie's interest became public. The cash and stock deal will leave Shire's current shareholders ...
Opinion/decision on a Paediatric Investigation ... [Published Opinion/decision on a Paediatric Investigation ... - Jul 15 2014]
News from the M&A Fronts [Published The Big Red Biotech Blog - Jun 27 2014]
Let's just wrap up this week with summaries on where we stand with various M&A activities -- with focus mainly on AbbVie and Shire, and Valeant and Allergan. AbbVie CEO Richard Gonzalez is making the rounds talking about the strategic value a succesful ...
Access to Big Data [Published I Am Biotech - Jun 26 2014]
Aquiring information rapidly and reliably reduces costs and advances discovery Sixty years ago, when James Watson and Francis Crick elucidated and published their seminal work on the double helical nature of DNA, they could hardly have imagined the ...
1 2 3 4 5 6
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.